keyword
MENU ▼
Read by QxMD icon Read
search

Neutropenia Fever

keyword
https://www.readbyqxmd.com/read/30505008/tocilizumab-in-the-treatment-of-systemic-onset-juvenile-idiopathic-arthritis-single-centre-experience
#1
Justyna Roszkiewicz, Krzysztof Orczyk, Elżbieta Smolewska
Objectives: The aim of the study was to evaluate the efficacy and long-term safety of tocilizumab treatment in children with systemic-onset juvenile idiopathic arthritis in a single centre. Material and methods: The study was based on a retrospective analysis of a cohort of 10 patients with systemic-onset juvenile idiopathic arthritis who were treated with tocilizumab in the period September 2011-July 2017. Their medical records were analysed taking into consideration the effectiveness of tocilizumab treatment and frequency of side effects...
2018: Reumatologia
https://www.readbyqxmd.com/read/30501868/dose-adjusted-epoch-r-etoposide-prednisone-vincristine-cyclophosphamide-doxorubicin-and-rituximab-in-untreated-aggressive-diffuse-large-b-cell-lymphoma-with-myc-rearrangement-a-prospective-multicentre-single-arm-phase-2-study
#2
Kieron Dunleavy, Michelle A Fanale, Jeremy S Abramson, Ariela Noy, Paolo Fabrizio Caimi, Stefania Pittaluga, Samir Parekh, Ann Lacasce, John W Hayslip, Deepa Jagadeesh, Sunil Nagpal, Mary Jo Lechowicz, Rakesh Gaur, Andrea Lucas, Christopher Melani, Mark Roschewski, Seth M Steinberg, Elaine S Jaffe, Brad Kahl, Jonathan W Friedberg, Richard F Little, Nancy L Bartlett, Wyndham H Wilson
BACKGROUND: MYC gene rearrangement is present in approximately 10% of aggressive B-cell lymphomas, with half also harbouring a BCL2 gene rearrangement. Multiple retrospective studies of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone or prednisolone) have shown a worse outcome in patients with MYC rearrangement (alone or with rearrangement of BCL2 or BCL6, or both) than in patients without MYC rearrangement, and suggest improved outcomes after more intensive treatment...
December 2018: Lancet Haematology
https://www.readbyqxmd.com/read/30498901/daptomycin-vs-glycopeptides-in-the-treatment-of-febrile-neutropenia-results-of-the-izmir-matched-cohort-study
#3
Oguz Resat Sipahi, Hasip Kahraman, Huseyin Aytac Erdem, Funda Yetkin, Selcuk Kaya, Tuna Demirdal, Ozlem Guzel Tunccan, Omer Karasahin, Ebru Oruc, Yasemin Cag, Behice Kurtaran, Mehmet Ulug, Murat Kutlu, Meltem Avci, Nefise Oztoprak, Bilgin Arda, Husnu Pullukcu, Meltem Tasbakan, Tansu Yamazhan, Ozlem Kandemir, Murat Dizbay, Hilal Sipahi, Sercan Ulusoy
PURPOSE: In this multicentre, retrospective, matched cohort study we aimed to evaluate the outcomes of neutropenic fever cases that were treated with daptomycin or a glycopeptide (vancomycin or teicoplanin). METHODS: Data and outcomes of adult (aged > 18-years old) patients with neutropenic fever [(1) without clinical and radiological evidence of pneumonia, (2) who were treated with daptomycin or a glycopeptide (teicoplanin or vancomycin) for any reason and for at least 72 h] were extracted from the hospital databases...
November 29, 2018: Infection
https://www.readbyqxmd.com/read/30473045/the-role-of-temperature-in-the-detection-and-diagnosis-of-neutropenic-sepsis-in-adult-solid-tumour-cancer-patients-receiving-chemotherapy
#4
Clare Warnock, Peter Totterdell, Angela Mary Tod, Rachel Mead, Jamie-Lee Gynn, Barry Hancock
PURPOSE: The primary aim of this study was to examine the value of temperature as a diagnostic and prognostic indicator of infection and sepsis in neutropenic patients. A secondary aim was to gain insight into the presenting symptoms reported by these patients at home or on their initial admission assessment. METHODS: A cohort study was carried out using a case note review of 220 emergency admissions to a regional cancer centre. All participants were neutropenic and were diagnosed with infection on admission...
December 2018: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://www.readbyqxmd.com/read/30461508/treatment-of-fever-in-neutropenia-in-pediatric-oncology-patients
#5
Thomas Lehrnbecher
PURPOSE OF REVIEW: Fever during neutropenia is a common occurrence in children with cancer. A number of studies have recently been performed to refine algorithms regarding initiation, modification, and termination of antimicrobial treatment and are the basis for international pediatric-specific guidelines for the treatment of fever and neutropenia in children with cancer. RECENT FINDINGS: Although hospitalization and prompt initiation of intravenous broad-spectrum antibiotics remains the mainstay in the treatment of febrile neutropenic children with cancer, recent research has addressed a number of questions to optimize the management of these patients...
November 16, 2018: Current Opinion in Pediatrics
https://www.readbyqxmd.com/read/30451720/neutropenia-in-glycogen-storage-disease-ib-outcomes-for-patients-treated-with-granulocyte-colony-stimulating-factor
#6
David C Dale, Audrey Anna Bolyard, Tracy Marrero, Merideth L Kelley, Vahagn Makaryan, Emily Tran, Jamie Leung, Laurence A Boxer, Priya S Kishnani, Stephanie Austin, Corbinian Wanner, Iris A Ferrecchia, Dina Khalaf, Dawn Maze, Joanne Kurtzberg, Cornelia Zeidler, Karl Welte, David A Weinstein
PURPOSE OF REVIEW: Glycogen storage disease Ib (GSD Ib) is characterized by hepatomegaly, hypoglycemia, neutropenia, enterocolitis and recurrent bacterial infections. It is attributable to mutations in G6PT1, the gene for the glucose-6-phosphate transporter responsible for transport of glucose into the endoplasmic reticulum. Neutropenia in GSD Ib is now frequently treated with granulocyte colony-stimulating factor (G-CSF). We formed a cooperative group to review outcomes of the long-term treatment of GSD Ib patients treated with G-CSF...
January 2019: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30448456/impact-of-empiric-treatment-for-vancomycin-resistant-enterococcus-vre-in-colonized-patients-early-after-allogeneic-hematopoietic-stem-cell-transplantation
#7
Mini Kamboj, Nina Cohen, Yao-Ting Huang, Marina Kerpelev, Ann Jakubowski, Kent A Sepkowitz, Genovefa A Papanicolaou, Susan K Seo
In recent years, vancomycin-resistant Enterococcus (VRE) colonization is increasingly being encountered among transplant populations, and VRE has become one of the leading causes of bacteremia early after allogeneic hematopoietic stem cell transplantation (allo-HSCT). There are sparse data regarding the effect of empiric VRE therapy for febrile, neutropenic allo-HSCT recipients colonized with VRE. All allo-HSCT patients aged 18 years and older who developed VRE bacteremia (VREB) between 2005-2014 were identified and categorized as to whether they received empiric versus (vs) directed VRE therapy...
November 15, 2018: Biology of Blood and Marrow Transplantation
https://www.readbyqxmd.com/read/30419425/early-neutropenia-with-thrombocytopenia-following-alemtuzumab-treatment-for-multiple-sclerosis-case-report-and-review-of-literature
#8
G T Maniscalco, I Cerillo, G Servillo, M Napolitano, G Guarcello, V Abate, G Improta, C Florio
Alemtuzumab is a monoclonal antibody targeting the CD52 antigen used in the treatment of relapsing-remitting multiple sclerosis (RRMS). CD52 is expressed by lymphocytes and monocytes but less by neutrophils and not by platelets. We present a case of a 38-year-old woman with RRMS who developed early neutropenia with thrombocytopenia after alemtuzumab infusion. She had no fever or symptoms of infection or purpura. After two weeks her haematological disorders spontaneously resolved. We reported the first case of neutropenia and thrombocytopenia as a possible event occurring after alemtuzumab infusion in MS patients, even if in a mild grade...
December 2018: Clinical Neurology and Neurosurgery
https://www.readbyqxmd.com/read/30407457/early-discharge-of-pediatric-patients-with-cancer-fever-and-neutropenia-with-low-risk-of-systemic-infection
#9
Mariana Gil-Veloz, Daniel O Pacheco-Rosas, Fortino Solórzano-Santos, Miguel A Villasís-Keever, Yadira Betanzos-Cabrera, Guadalupe Miranda-Novales
Background: Ambulatory therapy in low-risk patients with cancer, fever, and neutropenia seems to be a secure and effective alternative. This study aimed to compare the effectiveness and safety of the antimicrobial treatment in early discharge vs. in-hospital treatment in children with cancer and febrile neutropenia (FN) with low risk of invasive bacterial infection (IBI). Methods: Quasi-experimental design with a historical cohort control group. Children with cancer during an episode of FN and low risk of IBI were included...
2018: Boletín Médico del Hospital Infantil de México
https://www.readbyqxmd.com/read/30382039/-examination-of-fever-risk-factors-after-prophylaxis-with-g-csf
#10
Yasunari Okuda, Misuzu Mori, Makoto Shinada, Hirofumi Fujii, Toshiaki Sudoh
Febrile neutropenia is a serious adverse drugreaction to cancer chemotherapy. Prophylactic administration of granulocyte colony-stimulatingfactor (G-CSF)is recommended in patients who require cancer chemotherapy associated with a risk of febrile neutropenia or intense treatment. However, we had patients who developed fever after prophylactic administration of G-CSF. This study investigated the risk factors of fever after prophylactic administration of G-CSF. The subjects were patients who underwent preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer and prophylactic administration of G-CSF...
October 2018: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/30364514/pembrolizumab-induced-agranulocytosis-in-a-pulmonary-pleomorphic-carcinoma-patient-who-developed-interstitial-lung-disease-and-ocular-myasthenia-gravis
#11
Takehiro Tozuka, Teppei Sugano, Rintaro Noro, Natsuki Takano, Kakeru Hisakane, Satoshi Takahashi, Toru Tanaka, Takeru Kashiwada, Susumu Takeuchi, Shinobu Kunugi, Yuji Minegishi, Yoshinobu Saito, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
An 82-year-old man with a recurrence of pulmonary pleomorphic carcinoma was treated with pembrolizumab. He achieved partial response after three cycles of pembrolizumab. However, he developed febrile neutropenia. A bone marrow aspiration sample revealed a decrease of mature neutrophils, and anti-neutrophil antibody was detected in blood. Computed tomography scans revealed consolidation in the right lung. Pathological findings in lung biopsy tissue revealed organizing pneumonia. Pembrolizumab-induced agranulocytosis and interstitial lung disease (ILD) were diagnosed...
November 2018: Oxford Medical Case Reports
https://www.readbyqxmd.com/read/30332497/a-phase-i-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-cxd101-in-patients-with-advanced-cancer
#12
Toby A Eyre, Graham P Collins, Avinash Gupta, Nicholas Coupe, Semira Sheikh, John Whittaker, Lai Mun Wang, Leticia Campo, Elizabeth Soilleux, Finn Tysoe, Richard Cousins, Nick La Thangue, Lisa K Folkes, Michael R L Stratford, David Kerr, Mark R Middleton
BACKGROUND: In the current study, the authors sought to determine the maximum tolerated dose (MTD) of the novel class 1 selective histone deacetylase inhibitor CXD101 in a dose escalation study in patients with advanced solid tumors or recurrent/refractory lymphoma. METHODS: The authors escalated the dose of CXD101 from 1 mg twice daily orally for 5 days in a 21-day cycle (3+3 design). RESULTS: A total of 39 patients were enrolled, 36 of whom received CXD101...
October 17, 2018: Cancer
https://www.readbyqxmd.com/read/30306327/prospective-study-of-a-web-mediated-management-of-febrile-neutropenia-related-to-chemotherapy-bioconnect
#13
Fabrice Denis, Eric Voog, Yoann Pointreau, Hugues Bourgeois, Valérie Seegers, Katell Le Du
BACKGROUND: We aimed to investigate whether patient self-evaluated symptoms transmitted via Internet is feasible between planned visits to provide an early management of fever and neutropenia induced by chemotherapy, and if it can reduce hospitalizations for severe neutropenia. METHODS: Patients who received a chemotherapy regimen with an overall risk of febrile neutropenia ≥ 20% had to report daily temperature between physician planned visits using a web application...
October 10, 2018: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/30294330/the-role-of-complement-activating-collectins-and-associated-serine-proteases-in-patients-with-hematological-malignancies-receiving-high-dose-chemotherapy-and-autologous-hematopoietic-stem-cell-transplantations-auto-hsct
#14
Anna S Świerzko, Mateusz Michalski, Anna Sokołowska, Mateusz Nowicki, Łukasz Eppa, Agnieszka Szala-Poździej, Iwona Mitrus, Anna Szmigielska-Kapłon, Małgorzata Sobczyk-Kruszelnicka, Katarzyna Michalak, Aleksandra Gołos, Agnieszka Wierzbowska, Sebastian Giebel, Krzysztof Jamroziak, Marek L Kowalski, Olga Brzezińska, Steffen Thiel, Jens C Jensenius, Katarzyna Kasperkiewicz, Maciej Cedzyński
We conducted a prospective study of 312 patients (194 with multiple myeloma, 118 with lymphomas) receiving high-dose conditioning chemotherapy and autologous hematopoietic stem cell transplantation (auto-HSCT). Polymorphisms of MBL2 and MASP2 genes were investigated and serial measurements of serum concentrations of mannose-binding lectin (MBL), CL-LK collectin and MASP-2 as well as activities of MBL-MASP-1 and MBL-MASP-2 complex were made. Serum samples were taken before conditioning chemotherapy, before HSCT and once weekly after (totally 4-5 samples); in minority of subjects also 1 and/or 3 months post transplantation...
2018: Frontiers in Immunology
https://www.readbyqxmd.com/read/30274405/clinical-features-and-laboratory-findings-of-travelers-returning-to-south-australia-with-dengue-virus-infection
#15
Emma J Quinn, Allena H-C Cheong, Julie K Calvert, Geoffrey Higgins, Trish Hahesy, David L Gordon, Jillian M Carr
Reported cases of dengue are rising in South Australia (SA) in travellers returning from dengue-endemic regions. We have undertaken a retrospective analysis to identify the clinical and laboratory characteristics of patients returning to SA with suspected dengue virus (DENV) infection. From 488 requests, 49 (10%) were defined by serology as acute dengue, with the majority of patients (75%) testing as non-structural protein 1 (NS1) and/or IgM positive. Dengue was most commonly acquired in Indonesia (42.9%) with clinical features of fever (95%), headache (41%) and myalgia/arthralgia (56%)...
January 7, 2018: Tropical Medicine and Infectious Disease
https://www.readbyqxmd.com/read/30259115/urine-cultures-at-the-onset-of-febrile-neutropenia-rarely-impact-antibiotic-management-in-asymptomatic-adult-cancer-patients
#16
Sam E Grigg, Patrick Date, Zoe Loh, Ortis Estacio, Douglas F Johnson, Eliza A Hawkes, Andrew Grigg
PURPOSE: There is a paucity of data regarding the utility of routine urine cultures in adults with febrile neutropenia (FN) without urinary symptoms receiving protocolised antibiotics. This is reflected by inconsistent recommendations in international and regional FN guidelines. We addressed this issue by retrospectively reviewing the impact of routine urine cultures on antibiotic management in haematology cancer inpatients at a tertiary hospital. METHODS: All haematology inpatients over a 5-year period (2011-2015) were retrospectively reviewed for episodes of FN (neutrophil count < 0...
September 27, 2018: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/30258624/frequency-of-bloodstream-infection-in-febrile-neutropenic-patients-experience-from-a-developing-country
#17
Basit Siddiqui, Rabeea Azmat, Shiyam Sunder Tikmani, Shumaila Rafi, Beenish Syed, Muhammad Tahir Khan, Hareem Rehman, Saleemullah Paracha
Introduction: About 20% of febrile neutropenic patients are presented with bloodstream infection which is a leading cause of mortality among these patients. Awareness of the locally prevalent pathogens and their susceptibility pattern is important for proper treatment of infection which improves survival in these patients. The objective of this study was to determine the frequency of bloodstream infection in patients with febrile neutropenia admitted in Abbasi Shaheed Hospital. Methods: This cross-sectional study was conducted in the Medical wards in Abbasi Shaheed Hospital, Karachi from 21-2-2016 to 20-8-2017...
October 2018: Annals of Medicine and Surgery
https://www.readbyqxmd.com/read/30250602/fanconi-anemia-in-twins-with-neutropenia-a-case-report
#18
Wenjun Deng, Mingyi Zhao, Yingting Liu, Lizhi Cao, Minghua Yang
Fanconi anemia (FA) is a rare inherited disease caused by mutations in genes that are primarily involved in DNA damage response or repair. The disease is often characterized by congenital malformations, progressive bone marrow failure, abnormal skin pigmentation patterns and susceptibility to cancer. The present study describes a pair of 4-year-old male twins, both of whom had been suffering from upper respiratory tract infections for >2 years. There was no indication of discomfort including fever, coughing, bleeding or fatigue from either child when the upper respiratory tract infection disappeared...
October 2018: Oncology Letters
https://www.readbyqxmd.com/read/30247950/complementary-treatment-with-mistletoe-extracts-during-chemotherapy-safety-neutropenia-fever-and-quality-of-life-assessed-in-a-randomized-study
#19
RANDOMIZED CONTROLLED TRIAL
Florian Pelzer, Wilfried Tröger, Dr Rer Nat
OBJECTIVES: Evaluate the safety and clinical response of complementary treatment with European mistletoe extracts during chemotherapy. DESIGN: Monocentric controlled trial with 95 patients randomized into three groups. SETTINGS/LOCATION: National Cancer Research Center of Serbia. SUBJECTS: Breast cancer patients (stage T1-3 N0-2 M0 ) undergoing surgery and adjuvant chemotherapy with six cycles of cyclophosphamide, adriamycin, and 5-fluorouracil...
September 2018: Journal of Alternative and Complementary Medicine: Research on Paradigm, Practice, and Policy
https://www.readbyqxmd.com/read/30242225/assessing-the-efficacy-of-an-ambulatory-peripheral-blood-hematopoietic-stem-cell-transplant-program-using-reduced-intensity-conditioning-in-a-low-middle-income-country
#20
José Carlos Jaime-Pérez, Lorena Salazar-Cavazos, Patrizia Aguilar-Calderón, José Luis Herrera-Garza, César Homero Gutiérrez-Aguirre, David Gómez-Almaguer
Efficacy of an ambulatory hematopoietic stem cell transplant (HSCT) program with a reduced intensity conditioning regimen (RIC) in malignant hematological diseases was assessed. We analyzed 217 patients who underwent HSCT from August 2013 to July 2017. There were 78 (35.9%) HLA-identical, 56 (25.8%) haploidentical, and 83 (38.2%) autologous transplants. Two-year transplant-related mortality (TRM) for HLA-identical, haploidentical, and auto grafts were 20%, 25%, and 2.5%; relapse/progression was 44%, 60%, and 55%; overall survival (OS) was 61%, 44...
September 21, 2018: Bone Marrow Transplantation
keyword
keyword
160871
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"